The Wright Group, led by Associate Professor Edwina Wright, is leading a ground breaking Victorian pre-exposure prophylaxis (PrEP) demonstration project to study the efficacy of daily antiretroviral therapy for the prevention of HIV in people who are at high risk of infection.

This could include relationships in which one partner is HIV positive and the other is HIV negative. A combination of PrEP with safe sex has shown in international studies to reduce infection by at least half.

In collaboration with the Alfred Hospital, Associate Professor Mark Stoové and investigators at other sites, this study brings together clinical, social and epidemiological aspects of the uptake of PrEP and will provide critical information for the introduction of PrEP in a comprehensive HIV strategy in Australia.